| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revvity, Inc. (RVTY) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RVTY is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 96.8K | $9.59M | - | |
| Other | 32.4K | $3.21M | - | |
| Other | 12.2K | $1.21M | - | |
| Other | 10.4K | $1.03M | - | |
| VP | 7.3K | $721.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2017 | Sullivan Patrick J | Director | Sale+OE | 6,628 | $62.59 | $414,833.26 | -15.4% | |
| May 4, 2017 | Friel Robert F | President And CEO | Sale+OE | 25,100 | $60.00 | $1,506,000.00 | -4.2% | |
| May 1, 2017 | Friel Robert F | President And CEO | Sale+OE | 48,400 | $60.01 | $2,904,484.00 | -7.8% | |
| Apr 27, 2017 | Friel Robert F | President And CEO | Sale+OE | 124,837 | $60.11 | $7,503,952.07 | -17.9% | |
| Mar 20, 2017 | Okun Andrew76 | Please See Remarks | Sell | 3,000 | $57.27 | $171,810.00 | -19.4% | |
| Mar 13, 2017 | Wilson Frank Anders | Please See Remarks | Sale+OE | 37,535 | $55.45 | $2,081,390.82 | -36.6% | |
| Mar 13, 2017 | Goldberg Joel S58 | Please See Remarks | Sale+OE | 30,710 | $55.45 | $1,702,930.92 | -33.5% | |
| Feb 21, 2017 | Michas Alexis P68 | Director | Sale+OE | 8,308 | $55.60 | $461,924.80 | -13.5% | |
| Feb 15, 2017 | Singh Prahlad R.53 | Please See Remarks | Sale+OE | 9,576 | $55.00 | $526,680.00 | -22.7% | |
| Feb 9, 2017 | Sato Vicki L73 | Director | Sale+OE | 8,308 | $54.01 | $448,715.08 | -21.7% |